Understanding rare disease pathogenesis: A grand challenge for model organisms

Genetics

Volumn 198, Issue 2, 2014, Pages 443-445

  Hieter, Philip ^a   Boycott, Kym M ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENETIC DISORDER; GENETIC IDENTIFICATION; HUMAN; NONHUMAN; ORGANISMS; PATHOGENESIS; RARE DISEASE; SCIENTIST; ZEBRA FISH; ANIMAL; FEMALE; GENETICS; MALE; MICROCEPHALY;

RIBOSOME PROTEIN;

ANIMALS; FEMALE; HUMANS; MALE; MICROCEPHALY; RIBOSOMAL PROTEINS;

EID: 84908046839     PISSN: 00166731     EISSN: 19432631     Source Type: Journal    
DOI: 10.1534/genetics.114.170217     Document Type: Article

References (14)

1. Altshuler, D., 2012 2011 Curt Stern Award Address. Am. J. Hum. Genet. 90(3): 407–409.
2. Baird, P. A., T. W. Anderson, H. B. Newcombe, and R. B. Lowry, 1988 Genetic disorders in children and young adults: a population study. Am. J. Hum. Genet. 42(5): 677–693.
3. Beaulieu, C. L., J. Majewski, J. Schwartzentruber, M. E. Samuels, B. A. Fernandez et al., 2014 FORGE Canada Consortium: outcomes of a 2-year national rare disease gene discovery project. Am. J. Hum. Genet. 94: 809–817.
4. Botstein, D., 2012 Why we need more basic biology research, not less. Mol. Biol. Cell 23(21): 4160–4161.
5. Boycott, K. M., M. R. Vanstone, D. E. Bulman, and A. E. Mackenzie, 2013 Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat. Rev. Genet. 14: 681–691.
6. Brooks, S. S., A. L. Wall, C. Golzio, D. W. Reid et al., 2014 Dysfunction of 60S ribosomal protein L10 (RPL10) disrupts neurodevelopment and causes X-linked microcephaly. Genetics 198: 723–733.
7. Carter, C. O., 1977 Monogenic disorders. J. Med. Genet. 14(5): 316–320.
8. Dolinski, K., and D. Botstein, 2007 Orthology and functional conservation in eukaryotes. Annu. Rev. Genet. 41: 465–507.
9. McGary, K. L., T. J. Park, J. O. Woods, H. J. Cha, J. B. Wallingford et al., 2010 Systematic discovery of nonobvious human disease models through orthologous phenotypes. Proc. Natl. Acad. Sci. USA 107(14): 6544–6549.
10. Rine, J., 2014 A future of the model organism model. Mol. Biol. Cell 25(5): 549–553.
11. Samuels, M. E., 2010 Saturation of the human phenome. Curr Genomics 11(7):482–499.
12. Sander, J. D., and J. K. Joung, 2014 CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 32(4): 347–355.
13. Spradling, A., B. Ganetsky, P. Hieter, M. Johnston, M. Olson et al., 2006 New roles for model genetic organisms in understanding and treating human disease: report from the 2006 Genetics Society of America meeting. Genetics 172(4): 2025–2032.
14. Watson, J. D., 1990 The human genome project: past, present, and future. Science 248(4951): 44–49.